GLP-1

GLP-1 symptom diary: describe what happened clearly

Record symptom onset, duration and impact without trying to diagnose through an app.

Leia este artigo em português
Open notebook with blank pages on a sofa, a hand holding a coral pencil and a glass of water nearby.
Illustrative image. It does not show a treatment outcome.

Details can fade between experiencing a symptom and discussing it at an appointment. A symptom diary helps preserve those details. Its role is clearer communication and assessment, rather than determining causation or replacing timely care when you need it.

Describe the experience before interpreting it

Start with what you noticed: nausea, vomiting, discomfort, dizziness or another symptom. Add location, onset and whether it changed through the day. Avoid writing a conclusion such as “medicine reaction” before assessment. An event occurring after treatment can have a temporal relationship without proving causation. Meals, infection, other medicines and existing conditions may also matter. Neutral descriptions let your professional consider these possibilities without first undoing an assumption embedded in every entry. Record the uncertainty honestly when you cannot identify an exact starting time.

Keep intensity and impact understandable

A simple personal scale can help if its meaning remains consistent across days. Explain the impact: did it interrupt a meal, wake you at night, prevent work or lead to medical care? Include duration and recurrence. A number alone, such as “nausea 6,” does not communicate the complete experience. If you change your approach to scoring intensity, record that change. The purpose is understandable comparison of descriptions, rather than creating a validated clinical measurement or independently deciding which symptoms are safe to ignore.

Brief context can still be relevant

Note nearby events such as a new medicine, food changes, travel, fever or a professionally advised plan change. With vomiting or difficulty drinking, describe what you observed without independently calculating a fluid target. Product safety information and Anvisa warnings show why relevant symptoms deserve assessment. Severe or persistent abdominal pain, substantial vomiting, difficulty retaining fluids or signs of a serious allergic reaction warrant care according to the situation. A diary should never delay that response. Documentation can be completed afterward when immediate care is the priority.

An example note without a presumed diagnosis

“Thursday, nausea started at 2 pm; lasted about two hours; interrupted lunch; no vomiting; also had a headache; started another medicine this week; question: when should I contact the team if this repeats?” The entry separates facts, context and a question. If you sought care, record the date, guidance received and subsequent changes. Do not retrospectively invent an intensity you cannot remember. Estimates are useful when labeled as estimates, and unknown fields should remain visible instead of being filled with a confident guess.

Prepare a review that preserves important episodes

At your appointment, select repeated, new or disruptive episodes while keeping access to the original dates. Identify the exact product and all medicines used. Ask which signs require immediate contact and which can be followed over an agreed period. Suspected adverse events may also need reporting through your country’s official channels; a professional can help with the process. A report documents suspicion rather than automatically proving causation. The diary’s value comes from accurate description and appropriate follow-up, including a clear record of questions your healthcare team still needs to answer.

Frequently asked questions

Can the app identify an adverse effect?

No. It organizes personal data. Diagnosis, causal assessment and treatment decisions require healthcare professionals.

Should I wait for several episodes before contacting someone?

No. A serious, intense or concerning symptom may require immediate contact or care. Agree on specific criteria with your healthcare team.

Sources and references

Documents and research consulted for this article. Each source describes its own context; a reference does not confirm every use of a substance.

  1. Alerta de farmacovigilância sobre pancreatite e GLP-1 (opens in a new tab)Anvisa · Accessed October 14, 2026
  2. Wegovy tablets and injection: prescribing information (opens in a new tab)FDA · Accessed October 14, 2026
  3. Zepbound: prescribing information, January 2026 (opens in a new tab)FDA · Accessed October 14, 2026